Pegihep 80mcg Injection
By Pegihep
Rx
1 Injection in a Vial

Composition
Pegylated Interferon Alpha 2B(80mcg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
April, 2026

liver
Caution should be exercised when considering the use of Pegihep 80mcg Injection in individuals with liver disease. Due to limited available information on how this medication affects the liver, it is crucial to consult your doctor before starting treatment. Your healthcare provider will be able to assess your individual situation and provide guidance on the safe use of Pegihep 80mcg Injection if you have liver issues.

kidney
Pegihep 80mcg Injection may not be safe for individuals with kidney disease and should be avoided. Patients with renal impairment should use caution. Consult with your doctor before using Pegihep 80mcg Injection.

alcohol
When using Pegihep 80mcg Injection, caution is advised when consuming alcohol. It is important to consult your doctor regarding alcohol intake with this medication.

driving
While on Pegihep 80mcg Injection, patients may experience dizziness, confusion, somnolence, and fatigue, which can impact their ability to drive safely. It is advised to avoid driving if these side effects occur.

pregnancy
Pegihep 80mcg Injection may be unsafe during pregnancy as animal studies indicate potential harm to the developing baby. Consult your doctor before using.

breastfeeding
Pegihep 80mcg Injection appears safe during breastfeeding, as per limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Interferons |
Therapeutic Class | - |
Action Class | Interferons |
₹12952.4
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024